Latham & Watkins represented Chardan Healthcare Acquisition 2 Corp. in the transaction. Renovacor, Inc. (Renovacor), an early-stage biotechnology company developing AAV-based gene therapies for devastating cardiovascular...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
